PGP and amyotrophic lateral sclerosis: In CNS conditions such as epilepsy [117,123,124], ALS [125], and brain tumours [3], P-gp expression and activity in the brain have been found to be upregulated as a consequence of disease, thereby contributing to pharmacotherapeutic failure since many drugs used to treat these conditions are substrates of P-gp.